Evidence map›Paper›PMID 31816816›Full record

ArticleInternational journal of molecular sciences2019

MicroRNA-451 and Genistein Ameliorate Nonalcoholic Steatohepatitis in Mice.

Mailin Gan, Linyuan Shen, Yuan Fan, Ya Tan, Ting Zheng, Guoqing Tang, Lili Niu, Ye Zhao, Lei Chen, Dongmei Jiang and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Genistein Promotes Skeletal Muscle Regeneration by Regulating miR-221/222.International journal of molecular sciences · 2022
    Article
  8. Genistein promotes M1 macrophage apoptosis and reduces inflammatory response by disrupting miR-21/TIPE2 pathway.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Medicines (Basel, Switzerland) · 2020
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mailin GanCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Linyuan ShenCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Yuan FanCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Ya TanCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Ting ZhengCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Guoqing TangCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Lili NiuCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Ye ZhaoCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Lei ChenCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Dongmei JiangCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Xuewei LiCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Shunhua ZhangCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Li ZhuCollege of Animal Science and Technology, Sichuan Agricultural University, Chengdu 611130, China.
Sichuan Agricultural University · CNAnimal Science Research Institute · CN

Funding

the National Key Research & Development Program of China; the National Natural Science Foundation of China; the Sichuan Sci & Tech Support Program; the earmarked fund for China Agriculture Research System. No.2018YFD0501004;No. 31530073;No. 2016NYZ0050 and No. SCSZTD-3-008;No. CARS-36-05B
6 · The paper itself

Abstract

Effective, targeted therapy for chronic liver disease nonalcoholic steatohepatitis (NASH) is imminent. MicroRNAs (miRNAs) are a potential therapeutic target, and natural products that regulate miRNA expression may be a safe and effective treatment strategy for liver disease. Here, we investigated the functional role of miR-451 and the therapeutic effects of genistein in the NASH mouse model. MiR-451 was downregulated in various types of liver inflammation, and subsequent experiments showed that miR-451 regulates liver inflammation via IL1β. Genistein is a phytoestrogen with anti-inflammatory and anti-oxidant effects. Interestingly, we found that the anti-inflammatory effects of genistein were related to miR-451 and was partially antagonized by the miR-451 inhibitor. MiR-451 overexpression or genistein treatment inhibited IL1β expression and inflammation. Taken together, this study shows that miR-451 has a protective effect on hepatic inflammation, and genistein can be used as a natural promoter of miR-451 to ameliorate NASH.

Indexed as

AnimalsBase SequenceCell LineDiet, High-FatDown-RegulationFemaleGenisteinHumansInflammationInterleukin-1betaLipopolysaccharidesLiverLiver NeoplasmsMice, Inbred ICRMicroRNAsNon-alcoholic Fatty Liver DiseaseGenisteinInterleukin-1betaLipopolysaccharidesMicroRNAsMirn451 microRNA, mousegenisteinhepatocarcinomamiR-451NASH

Identifiers

PMID31816816
PMCPMC6928943
OpenAlexW2989616991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.